YHR218W-A Antibody

What is the YHR218W-A antibody and what is known about its target protein?

YHR218W-A antibody is a monoclonal antibody generated against the YHR218W protein encoded by the YHR218W gene in Saccharomyces cerevisiae (baker's yeast). The target protein (UniProt ID P38899) is classified as a hypothetical protein with currently uncharacterized function. This antibody serves as a valuable research tool for investigating this poorly understood yeast protein.

What are the primary applications for YHR218W-A antibody in yeast biology research?

The YHR218W-A antibody finds utility in multiple fundamental research applications:

• Protein localization studies: Used in immunofluorescence and immunohistochemistry experiments to map the subcellular distribution patterns of the target protein

• Protein expression analysis: Applied in Western blotting to detect and quantify expression levels

• Protein-protein interaction studies: Employed in immunoprecipitation assays to identify binding partners

• Functional validation: Used to confirm target specificity in knockout cell lines

What experimental validation approaches are recommended for YHR218W-A antibody?

While specific validation data for YHR218W-A is not extensively documented in public databases, industry standards suggest implementing these rigorous testing protocols:

These validation approaches help establish antibody specificity and reliability for downstream applications.

How should researchers design experiments to investigate YHR218W-A function using antibody-based approaches?

When designing experiments to investigate YHR218W-A function, researchers should implement a multi-faceted approach:

• Establish appropriate controls: Include both positive (wild-type yeast strains) and negative controls (YHR218W knockout strains) in all experiments

• Optimize antibody concentration: Perform titration experiments to determine optimal antibody concentration for each application

• Validate specificity: Confirm antibody specificity using Western blotting with knockout controls before proceeding to more complex applications

• Combine multiple techniques: Integrate antibody-based approaches with complementary techniques such as fluorescent protein tagging or mass spectrometry

• Consider strain backgrounds: Test antibody performance across different yeast strain backgrounds to account for genetic variation effects

What are the optimal fixation and permeabilization conditions for immunofluorescence studies with YHR218W-A antibody?

For immunofluorescence applications, the following protocol considerations are recommended:

• Fixation options:

  • 4% paraformaldehyde for 15-20 minutes (preserves structural integrity)

  • 70% ethanol for membrane proteins (may improve epitope accessibility)

• Permeabilization strategies:

  • 0.1-0.5% Triton X-100 for 5-10 minutes (standard approach)

  • Digitonin (0.01-0.1%) for selective plasma membrane permeabilization

  • Saponin (0.1-0.5%) for reversible permeabilization

• Blocking conditions:

  • 5% BSA or 5-10% normal serum from the species unrelated to the secondary antibody

  • Include 0.1% Tween-20 to reduce background

The specific conditions should be empirically optimized based on the subcellular localization of YHR218W-A and the particular yeast strain being studied.

How can researchers use YHR218W-A antibody to investigate protein-protein interactions?

Researchers can employ several methodological approaches using YHR218W-A antibody to explore protein-protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Lyse yeast cells under non-denaturing conditions

  • Incubate lysate with YHR218W-A antibody immobilized on protein A/G beads

  • Wash extensively to remove non-specific interactions

  • Elute bound proteins and analyze by Western blot or mass spectrometry

• Proximity-dependent labeling:

  • Create a fusion protein with YHR218W-A and a proximity labeling enzyme (BioID or APEX)

  • Express in yeast and activate labeling

  • Use the antibody to validate fusion protein expression

  • Purify biotinylated proteins and identify by mass spectrometry

• Fluorescence microscopy with co-localization:

  • Use YHR218W-A antibody alongside antibodies against potential interacting partners

  • Quantify co-localization using appropriate statistical measures

  • Confirm interactions with complementary techniques

What are the common pitfalls in epitope accessibility when using YHR218W-A antibody, and how can they be addressed?

Several factors can affect epitope accessibility when working with YHR218W-A antibody:

Regarding epitope structure, typical antibody epitopes contain approximately 14.6 ± 4.9 residues, with heavy chain paratopes contributing about 67% of the total interaction. Hydrophobic interactions represent about 40% of interface residues, while hydrogen bonds account for approximately 30% of interfacial contacts.

How should researchers interpret Western blot results with YHR218W-A antibody in the context of yeast cell cycle studies?

When analyzing Western blot results with YHR218W-A antibody in yeast cell cycle studies:

• Quantification approach:

  • Normalize YHR218W-A signal to stable housekeeping proteins (e.g., actin, tubulin)

  • Use biological replicates (n≥3) for statistical analysis

  • Apply appropriate statistical tests (ANOVA for multiple timepoints)

• Cell cycle synchronization considerations:

  • Compare expression across multiple synchronization methods (α-factor, hydroxyurea, nocodazole)

  • Include asynchronous culture controls

  • Validate synchronization efficiency using known cell cycle markers

• Interpretation framework:

  • Correlate expression patterns with cell cycle phases

  • Consider possible post-translational modifications affecting mobility

  • Integrate with transcriptional data from microarray or RNA-seq studies

  • Compare with related genes/proteins in cluster analysis

What controls are essential when evaluating antibody specificity in immunoprecipitation experiments?

For rigorous validation of YHR218W-A antibody specificity in immunoprecipitation experiments, the following controls are essential:

• Positive controls:

  • Wild-type yeast expressing endogenous levels of YHR218W-A

  • Yeast overexpressing tagged YHR218W-A protein

• Negative controls:

  • YHR218W-A knockout strain

  • Isotype control antibody (same species and isotype, irrelevant specificity)

  • Pre-immune serum (for polyclonal antibodies)

  • Beads-only control (no antibody)

• Validation approaches:

  • Reciprocal co-IP (if interacting partners are identified)

  • Mass spectrometry confirmation of immunoprecipitated proteins

  • Competition with purified antigen or blocking peptide

How can YHR218W-A antibody studies be integrated with gene expression profiling for comprehensive functional analysis?

Integrating YHR218W-A antibody studies with gene expression profiling enables a multi-omics approach to functional characterization:

• Correlation analysis workflow:

  • Perform Western blot quantification of YHR218W-A protein levels

  • Conduct parallel RNA-seq or microarray analysis

  • Calculate protein-mRNA correlation coefficients

  • Identify conditions where protein and mRNA levels are discordant (suggesting post-transcriptional regulation)

• Superparamagnetic clustering integration:

  • Use YHR218W-A protein expression data as a seed for clustering

  • Identify co-expressed genes through superparamagnetic clustering

  • Enhance clustering by incorporating transcription factor binding information

  • Compare clusters between standard SPC and SPCTF (SPC with transcription factor data)

• Functional network construction:

  • Map YHR218W-A within existing yeast protein interaction networks

  • Validate key interactions using antibody-based approaches

  • Integrate with genetic interaction data (synthetic lethality, epistasis)

  • Use network analysis to predict cellular functions

What are the methodological considerations when using YHR218W-A antibody in combination with CRISPR-Cas9 gene editing?

When implementing CRISPR-Cas9 gene editing in conjunction with YHR218W-A antibody studies, researchers should address these methodological considerations:

• Experimental design strategy:

  • Design sgRNAs with minimal off-target effects

  • Create precise genetic modifications (knockout, point mutations, tags)

  • Validate edits by sequencing and Western blot with YHR218W-A antibody

  • Assess clonal variation in antibody reactivity

• Validation framework:

  • Compare antibody signal across multiple independently derived clones

  • Include wild-type controls in every experiment

  • Verify specificity with multiple sgRNAs targeting different regions

  • Consider creating epitope-specific mutations to map binding sites

• Functional assessment approach:

  • Use the antibody to assess protein expression in edited cells

  • Monitor localization changes resulting from specific mutations

  • Investigate protein stability alterations in different genetic backgrounds

  • Analyze protein-protein interaction changes in edited cells

How might YHR218W-A antibody be utilized in studying conserved protein functions across different yeast species?

The YHR218W-A antibody presents valuable opportunities for comparative studies across yeast species:

• Cross-species reactivity assessment:

  • Test antibody recognition of orthologs in related yeasts (Candida, Schizosaccharomyces)

  • Identify conserved epitopes through sequence alignment

  • Generate species-specific antibodies for comparative studies

• Evolutionary conservation analysis:

  • Use the antibody to compare expression patterns across species

  • Correlate protein conservation with functional conservation

  • Identify species-specific post-translational modifications or interactions

• Heterologous expression systems:

  • Express YHR218W-A orthologs in S. cerevisiae

  • Use the antibody to monitor expression, localization, and interactions

  • Assess functional complementation in knockout backgrounds

What emerging technologies could enhance the research applications of YHR218W-A antibody?

Several cutting-edge technologies can extend the research utility of YHR218W-A antibody:

• Advanced imaging applications:

  • Super-resolution microscopy (STORM, PALM) for precise localization

  • Live-cell imaging with antibody fragments or nanobodies

  • Correlative light-electron microscopy for ultrastructural context

• Single-cell applications:

  • Mass cytometry (CyTOF) for protein expression in single cells

  • Microfluidic antibody-based assays for single-cell analysis

  • In situ proximity ligation for detecting interactions at single-molecule resolution

• Structural biology integration:

  • Cryo-electron microscopy with antibody labeling

  • Hydrogen-deuterium exchange mass spectrometry for epitope mapping

  • Protein footprinting combined with antibody recognition to track conformational changes